Sort
34,240 grants matching “atherosclerosis”
SPPACE INSTI Study: Sex-specific Predictors, Pathways, And Cardiometabolic Effects of Weight Gain Associated with Integrase Strand-Transfer Inhibitors
$676,556Cecile Delille Lahiri · Emory University · R01 · FY2025 · DK
Cardiopulmonary Risk Assessment from Smoke Exposure at the Wildland Urban Interface
$676,467Jessica M Oakes · Northeastern University · R01 · FY2025 · ES
A Social Epigenomic Approach to Health Disparities in Cardiovascular Risk Factors
$676,386Jennifer Ann Smith · University Of Michigan At Ann Arbor · R01 · FY2020 · HL
MRI Determination of Carotid Atherosclerosis Progression
$676,361Northern California Institute Res &Educ · R01 · FY2004 · NS
Molecular Mechanisms Regulating Endothelial Dysfunction
$676,330Hong Chen · Boston Children'S Hospital · R01 · FY2020 · HL
Molecular Mechanisms Regulating Endothelial Dysfunction
$676,330Hong Chen · Boston Children'S Hospital · R01 · FY2018 · HL
Molecular Mechanisms Regulating Endothelial Dysfunction
$676,330Hong Chen · Boston Children'S Hospital · R01 · FY2019 · HL
Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease
$676,107Rozenn Lemaitre · University Of Washington · R01 · FY2020 · HL
EPICARDIAL ADIPOSE TISSUE, OBESITY AND INFLAMMATION IN ATHEROSCLEROSIS
$676,067Devendra K. Agrawal · Creighton University · R01 · FY2013 · HL
Mechanosensors that detect and treat Lung Fibrosis
$675,986Thomas Harrison Barker · University Of Virginia · R01 · FY2017 · HL
PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk
$675,980Thomas None Quertermous · Stanford University · R01 · FY2021 · HL
Preclinical Development of a Novel Plaque-Regressing Therapy For Atherosclerosis
$675,944Michael W Fanger · Celdara Medical, Llc · R43 · FY2012 · HL
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
$675,844Peter W Hunt · University Of California, San Francisco · R01 · FY2020 · HL
Genetic Mechanisms of Arteriosclerosis in Hypertensive Sibships
$675,842Sharon L Kardia · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
Personalized lesion modification optimizes atherosclerosis intervention
$675,758Elazer R Edelman · Massachusetts Institute Of Technology · R01 · FY2024 · HL
Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism
$675,710Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2024 · HL
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
$675,678Scott Michael Damrauer · University Of Pennsylvania · R01 · FY2025 · HL
Human Studies on Blood Levels of Glycated CD59 as a Biomarker in Diabetes
$675,664Jose A Halperin · Brigham And Women'S Hospital · R01 · FY2016 · DK
Autophagy and VSMC migration
$675,620Zhonglin Xie · Georgia State University · R01 · FY2017 · HL
Autophagy and VSMC migration
$675,620Zhonglin Xie · Georgia State University · R01 · FY2019 · HL
Autophagy and VSMC migration
$675,620Zhonglin Xie · Georgia State University · R01 · FY2018 · HL
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease
$675,558Brian H Annex · University Of Virginia · R01 · FY2015 · HL
Cardiopulmonary Risk Assessment from Smoke Exposure at the Wildland Urban Interface
$675,553Chiara Bellini · Northeastern University · R01 · FY2023 · ES
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
$675,539Iris Z Jaffe · Tufts Medical Center · R01 · FY2021 · HL
Assessing Long Term Outcomes of Living Donation
$675,501Bertram L Kasiske · University Of Minnesota · U01 · FY2012 · DK